Compensated cirrhosis: Natural history and prognostic factors

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/HEP.1840070124PMID 3804191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follow-up studies on an unselected ten-year material of 360 patients with liver cirrhosis in one community.

  2009cited by this paper
• Assessment of Prognostic Factors in Alcoholic Liver Disease: Toward a Global Quantitative Expression of Severity

  2007cited by this paper
• Prognostic Factors in Cirrhosis Identified by Cox's Regression Model

  2007cited by this paper
• Statistical Methods for Survival Data Analysis

  1994cited by this paper
• Prognostic Value of Child‐Turcotte Criteria in Medically Treated Cirrhosis

  1984cited by this paper
• Prognostic Value of Total Serum Bilirubin/γ‐Glutamyl Transpeptidase Ratio in Cirrhotic Patients

  1984cited by this paper
• Reticuloendothelial System Phagocytic Activity in Cirrhosis and Its Relation to Bacterial Infections and Prognosis

  1984cited by this paper
• Continued heavy drinking and survival in alcoholic cirrhotics

  1981cited by this paper
• Continued heavy drinking and survival in alcoholic cirrhotics.

  1981cited by this paper
• Statistical Methods for Survival Data Analysis

  1981cited by this paper
• A 20-year prospective study of cirrhosis.

  1981cited by this paper
• Factors related to length of complete remission in adult acute leukemia

  1980cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Reliability of assessment of alcohol intake based on personal interviews in a liver clinic.

  1979cited by this paper
• Epidemiology of alcoholic liver disease.

  1976cited by this paper
• Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study.

  1976cited by this paper
• The abnormal hepatic scan of chronic liver disease: its relationship to hepatic hemodynamics and colloid extraction.

  1976cited by this paper
• Studies in alcoholic liver disease in Britain

  1974cited by this paper
• Letter: Antral-gastrin-cell hyperplasia in peptic-ulcer disease.

  1974cited by this paper
• Hyperglobulinaemia in liver disease.

  1973cited by this paper
• Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data.

  1973cited by this paper
• Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

  1973cited by this paper
• EFFECT OF ALCOHOL ABSTINENCE ON SURVIVAL IN CIRRHOTIC PORTAL HYPERTENSION: Report from the Boston Inter-Hospital Liver Group

  1973cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• CIRRHOSIS OF THE LIVER A COMPARATIVE STUDY OF THE FOUR MAJOR ÆTIOLOGICAL GROUPS

  1971cited by this paper
• Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease.

  1968cited by this paper
• The natural history of cirrhosis. Experience with an unselected group of patients.

  1968cited by this paper
• Some aspects of the first recorded case of multiple myeloma.

  1967cited by this paper
• Treatment of hepatic coma by exchange blood transfusion.

  1966cited by this paper
• THE NATURAL HISTORY OF CIRRHOSIS. II. THE INFLUENCE OF ALCOHOL AND PRIOR HEPATITIS ON PATHOLOGY AND PROGNOSIS.

  1964cited by this paper
• The natural history of cirrhosis. I. Survival with esophageal varices.

  1963cited by this paper
• The Natural History of Cirrhosis

  1963cited by this paper
• Cirrhosis of the liver: a study of alcoholic and nonalcoholic patients in Boston and London.

  1960cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• The natural history of postnecrotic cirrhosis; a study of 221 autopsy cases.

  1958cited by this paper
• Surgery in hypertension.

  1948cited by this paper
• THE NATURAL HISTORY OF LAENNEC'S CIRRHOSIS OF THE LIVER AN ANALYSIS OF 386 CASES

  1942cited by this paper

• El futuro de la elastografía esplénica: ¿es una herramienta útil para el tratamiento personalizado?

  2026cites this paper
• Long-term results of peritoneovenous shunt implantation for refractory ascites in patients with alcoholic liver cirrhosis: single-center retrospective study of 348 patients

  2026cites this paper
• Serum-urine metabolic integration via UPLC-QTOF/MS uncovers shared pathway biomarkers for cirrhosis diagnosis.

  2026cites this paper
• Prognostic Value of an Early Response to Tolvaptan and Its Clinical Implications in Patients With Cirrhosis and Hepatic Edema: A Nationwide Multicenter Cohort Study.

  2026cites this paper
• Efficacy and Safety of Statins in MASLD and Other Chronic Liver Diseases.

  2026cites this paper
• Prognostic value of blood urea nitrogen to albumin ratio in critically ill cirrhotic patients with ascites.

  2026cites this paper
• PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study

  2025cites this paper
• Benefits of TIPS for Patients With Large Ascites Preceding Recurrent or Refractory ascites: A Multicenter Cohort Study

  2025cites this paper
• PERFORMANCE OF SIX PREDICTIVE MODELS OF DEATH OF PATIENTS HOSPITALIZED FOR DECOMPENSATED CIRRHOSIS: A MULTICENTER STUDY

  2025cites this paper
• Palliative long-term abdominal drains vs. large volume paracentesis for refractory ascites secondary to cirrhosis: protocol for a definitive randomised controlled trial (REDUCe2 study)

  2025cites this paper
• Prognostic significance of mild ascites in patients with cirrhosis.

  2025cites this paper
• Increased Mortality with Intermediate Ascitic Polymorphonuclear Cell Counts Amongst Patients with Cirrhosis: Time to Redefine the Care Approach

  2025cites this paper
• Exploring the Value of Combined Clinical Indicators and Multiphase Dynamic Contrast-Enhanced CT Imaging Characteristics for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma

  2025cites this paper
• Multiparametric MRI for Diagnosing Clinically Significant Portal Hypertension and Predicting Liver Decompensation

  2025cites this paper
• NASH-CHECK patient-reported outcome instrument: evaluation of content and face validity for patients with metabolic dysfunction–associated steatohepatitis and compensated cirrhosis

  2025cites this paper
• Ascites complications risk factors of decompensated cirrhosis patients: logistic regression and prediction model

  2025cites this paper
• Generative AI in hepatology: Transforming multimodal patient-generated data into actionable insights

  2025cites this paper
• Comparison of Zinc Levels in Liver Cirrhosis and Evaluating the Severity Using Child-Pugh Score

  2025cites this paper
• Liver cirrhosis: Ancient disease, new challenge

  2025cites this paper
• From Pathophysiology to Practice: Evolving Pharmacological Therapies, Clinical Complications, and Pharmacogenetic Considerations in Portal Hypertension

  2025cites this paper
• Feasibility study of a novel technique for treating refractory ascites using a peritoneobladder shunt in a swine model

  2025cites this paper
• Detecting decompensation in cirrhotic patients with varying ascitic volumes using magnetic resonance elastography.

  2025cites this paper
• EASL Clinical Practice Guidelines on TIPS.

  2025cites this paper
• Liver Cirrhosis: Causes, Severity, and Management Strategy

  2025cites this paper
• Liver Failure from Alcohol Takes on Several Forms: Decompensated Cirrhosis, Acute-on-Chronic Liver Failure, and Alcohol-Related Hepatitis.

  2025cites this paper
• TIPS in Patients With Refractory Ascites: Review of Literature and Current Recommendations.

  2025cites this paper
• Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management

  2025cites this paper
• Comparison of artificial neural network-predicted PPG and HVPG with measured PPG in decompensated cirrhosis patients

  2025cites this paper
• Study comparing rapid diagnostic test with conventional method in diagnosis of spontaneous bacterial peritonitis in liver cirrhosis

  2025cites this paper
• The CIRrhotic Ascites Severity (CIRAS) model predicts hepatic hydrothorax at all stages of ascites.

  2024cites this paper
• Physiological network approach to prognosis in cirrhosis: A shifting paradigm

  2024cites this paper
• Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan

  2024cites this paper
• Notfallmedizinisch relevante Komplikationen der Leberzirrhose

  2024cites this paper
• Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond

  2024cites this paper
• Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine

  2024cites this paper
• Clinical Implications of Inflammation in Patients With Cirrhosis

  2024cites this paper
• Ascitis y síndrome hepatorrenal en la cirrosis hepática

  2024cites this paper
• Effective palliation of refractory ascites in cirrhosis is challenging.

  2024cites this paper
• Ascites in cirrhotic patients: a comprehensive review

  2024cites this paper
• Acute and non‐acute decompensation of liver cirrhosis (47/130)

  2024cites this paper
• Ascites fluid calprotectin level is highly accurate in diagnosing spontaneous bacterial peritonitis: a preliminary proof of concept prospective study

  2024cites this paper
• Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis

  2024cites this paper
• Managing cirrhosis with limited resources: perspectives from sub-Saharan Africa.

  2024cites this paper
• Hyponatremia unleashes neutrophil extracellular traps elevating life-threatening pulmonary embolism risk

  2024cites this paper
• Correlation between the diameter of esophageal varices measured using a virtual ruler under endoscopy and portal pressure gradient

  2024cites this paper
• Evaluation of Serum C-Reactive Protein in Diagnosis of Spontaneous Bacterial Peritonitis in Patients with Cirrhosis of Liver and Ascites

  2024cites this paper
• Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis

  2024cites this paper
• Longitudinal evaluation of individuals with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype).

  2024cites this paper
• Liver Cirrhosis: ancient disease, new challenge.

  2024cites this paper
• Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma.

  2024cites this paper
• Differential Effects of Ascites and Hepatic Encephalopathy on Waitlist Mortality in Liver Transplantation by MELD 3.0

  2024cites this paper
• Dynamic liver volume change in predicting hepatic decompensation and long‐term effects of stereotactic body radiation therapy

  2024cites this paper
• Application of metagenomic next-generation sequencing in optimizing the diagnosis of ascitic infection in patients with liver cirrhosis

  2024cites this paper
• Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its Complications.

  2024cites this paper
• Outcomes in Cirrhosis-Related Refractory Ascites with Emphasis on Palliative Care: Single-Centre Experience and Literature Review

  2024cites this paper
• Long-term hemodynamic response of carvedilol and simvastatin in compensated versus decompensated chronic liver disease with portal hypertension

  2024cites this paper
• Prolonged use of pentoxifylline increases the life expectancy of patients with compensated cirrhosis: A 20‑year retrospective study

  2024influential citation
• Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites

  2024cites this paper
• Inpatient Hepatology Consultation: A Practical Approach for Clinicians.

  2023cites this paper
• Pharmacokinetics of AXA1665, a Novel Composition of Amino Acids, in Comparison With Protein Supplement: A Single‐Dose, Open‐Label, Randomized Study in Healthy Subjects

  2023cites this paper
• Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.

  2023cites this paper
• The progress to establish optimal animal models for the study of acute-on-chronic liver failure

  2023cites this paper
• Outcomes after hospitalisation with spontaneous bacterial peritonitis over a 13-year period: a retrospective cohort study

  2023cites this paper
• Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy

  2023cites this paper
• Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy

  2023cites this paper
• Echocardiographic hemodynamic assessment in decompensated cirrhosis: comparison between Intensivists and Gastroenterologists

  2023cites this paper
• Impact of decompensated cirrhosis in children: A population-based study.

  2023cites this paper
• The road to pandemic recovery: Tracking COVID-19’s impact on cirrhosis care and outcomes among 111,558 Veterans

  2023cites this paper
• Controversies in Liver Transplantation

  2023cites this paper
• The Role of Correcting Structural and Functional Albumin Properties in Ascites Control in Decompensated Cirrhotic Patients

  2023cites this paper
• Complicaciones agudas del paciente cirrótico. Ascitis, encefalopatía hepática y síndrome hepatorrenal

  2023cites this paper
• The Incidence of Spontaneous Bacterial Peritonitis in Patients With Cirrhosis-Related Ascites Undergoing Elective Outpatient Large-Volume Paracentesis

  2023cites this paper
• Uroperitoneo como causa de ascitis recurrente. Una etiología que no debe ser olvidada

  2023cites this paper
• Balloon-occluded Esophageal Varices Obliteration Versus Ligation for the Management of F2 Esophageal Varices: A Randomized Controlled Trial

  2023cites this paper
• Integrating smart phone applications in the management of cirrhotic patients: A scoping review

  2023cites this paper
• Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites

  2023cites this paper
• Prise en charge d’une ascite cirrhotique

  2023cites this paper
• Albumin-bilirubin score in non-malignant liver diseases should be properly validated

  2023cites this paper
• Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis

  2023cites this paper
• A Very Uncommon Case of Transudative Chylothorax: A Case Report and Literature Review

  2023cites this paper
• The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure.

  2023cites this paper
• Portal Venous Remodeling Determines the Pattern of Cirrhosis Decompensation: A Systems Analysis

  2023cites this paper
• Delayed Diagnostic Paracentesis Is Associated with Increased Preventable Healthcare Utilization in Disadvantaged Patient Populations with Advanced Liver Disease and Elevated INR

  2023cites this paper
• Challenges and Solutions for Monitoring Alcohol Use in Patients With Alcohol-Related Liver Disease: Pilot Study of a Wearable Alcohol Biosensor

  2023cites this paper
• Management of cirrhotic ascites: Seven‐step treatment protocol based on the Japanese evidence‐based clinical practice guidelines for liver cirrhosis 2020

  2023cites this paper
• The Effects of SGLT2 Inhibitors on Liver Cirrhosis Patients with Refractory Ascites: A Literature Review

  2023cites this paper
• Hipertensión portal

  2023cites this paper
• Can diffusion-weighted imaging be used in the examination of peritoneal fluids?

  2023cites this paper
• Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure

  2023cites this paper
• The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model

  2023cites this paper
• Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis

  2023cites this paper
• Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis

  2023cites this paper
• Acute Decompensated Liver: When to Transplant?

  2023cites this paper
• Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials

  2023cites this paper
• Algorithm of ascites management for liver cirrhosis in the tolvaptan era: Paradigm shift treatment improves the outcomes of cirrhotic patients?

  2023cites this paper
• SOP Aszitespunktion – Diagnostik, Indikation und Durchführung

  2023cites this paper
• Uroperitoneo como causa de ascitis recurrente. Una etiología que no debe ser olvidada

  2023cites this paper
• Lymphocyte to Monocyte Ratio and C-Reactive Protein Combination as the Best Simple Predictor of Treatment Response in Cirrhotic Patients with Culture Negative Neutrocytic Ascites

  2022cites this paper
• The role of peritoneal dialysis in the treatment of ascites

  2022cites this paper
• Determine the Frequency of Factors Leading to Hepatic Encephalopathy in Patients with Liver Cirrhosis

  2022cites this paper